fingolimod hydrochloride has been researched along with Lymph Node Metastasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abe, S; Hait, NC; Ichikawa, H; Ikarashi, M; Koyama, Y; Ling, Y; Moro, K; Nagahashi, M; Okuda, S; Sakata, J; Sato, N; Shimada, Y; Takabe, K; Takeuchi, S; Toshikawa, C; Tsuchida, J; Wakai, T | 1 |
Gu, Y; He, Z; Liu, H; Lu, M; Wang, C; Wang, H; Yin, J; Zhang, Z; Zheng, G | 1 |
Bae, DS; Cho, YJ; Choi, CH; Choi, JJ; Kim, BG; Kim, HS; Kim, TJ; Lee, JW; Lee, YY; Ryu, JY; Song, SY; Yoon, G | 1 |
3 other study(ies) available for fingolimod hydrochloride and Lymph Node Metastasis
Article | Year |
---|---|
Plasma Sphingosine-1-Phosphate Levels Are Associated with Progression of Estrogen Receptor-Positive Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Fingolimod Hydrochloride; Gene Expression; Humans; Lymphatic Metastasis; Lysophospholipids; MCF-7 Cells; Middle Aged; Plasma; Receptors, Estrogen; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors | 2021 |
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.
Topics: Animals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p27; Disease Progression; DNA-Binding Proteins; Extracellular Signal-Regulated MAP Kinases; Fingolimod Hydrochloride; Histone Chaperones; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Lymphatic Metastasis; Matrix Metalloproteinase 9; Mice; Neoplasm Staging; Prognosis; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transcription Factors; Transplantation, Heterologous | 2015 |
Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer.
Topics: Adult; Animals; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Disease Progression; Disease-Free Survival; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Fingolimod Hydrochloride; Formaldehyde; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Immunohistochemistry; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasm Transplantation; Paraffin Embedding; Phosphotransferases (Alcohol Group Acceptor); Prognosis; Thiazoles; Uterine Cervical Neoplasms | 2015 |